Wall Street was mixed with low volumes of trading Friday with major U.S. markets struggling to end in positive territory for ...
Wall Street is hanging near its record after companies turned in a mixed set of profit results. The S&P 500 slipped 0.1% in ...
The most talked about and market moving research calls around Wall Street are now in one place ... Bernstein downgraded Cigna (CI) to Market Perform from Outperform with a $323 price target.
Cigna closed out 2024 on shaky footing, posting fourth-quarter results below Wall Street’s expectations due to a rise in medical costs. Meanwhile, top executives pledged changes to medical and ...
UnitedHealthCare is under investigation by the Department of Justice again for its Medicare Advantage billing practices. This is one of several legal battles and extraordinary mishaps the insurer has ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top Upgrades ...
Cigna forecasts annual profit below Wall Street estimates Quarterly results hurt by higher stop loss medical costs Magnitude of Q4 miss was greater than anticipated, analysts said Jan 30 (Reuters ...
Wall Street's main indexes rose on Thursday, driven by post-earnings advances in Meta and Tesla, although Microsoft's weak cloud forecast and downbeat results from Cigna dampened investor enthusiasm.
Driven by a notable increase in pharmacy revenues, Cigna’s overall topline soared 28.4% year-over-year to $65.6 billion, surpassing the Street’s expectations by 3.9%. However, due to higher ...
Bloomfield, Connecticut-based The Cigna Group (CI) provides insurance and related products and services in the United States and internationally. With a market cap of $81.4 billion, Cigna operates ...
While Cigna's Q4 revenue of $65.65 billion beat Wall Street's estimate of $63.44, rising medical costs led to a much more significant earnings-per-share (EPS) miss. The company delivered $6.64 per ...